カテゴリ： 世界, 医療/バイオ, Market Monitor Global

電解質異常治療薬のグローバル市場展望 2023年-2029年：経口液、注射剤

■ 英語タイトル：Drugs for Electrolyte Disorders Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8488）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8488
■ 発行日：2023年7月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：119
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥481,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥625,300見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥721,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[電解質異常治療薬のグローバル市場展望 2023年-2029年：経口液、注射剤]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の電解質異常治療薬市場規模と予測を収録しています。・世界の電解質異常治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の電解質異常治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の電解質異常治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口液」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

電解質異常治療薬のグローバル主要企業は、Nomax Inc.、 Bristol Myers Squibb、 AbbVie、 Upsher-Smith Laboratories, Inc.、 AstraZeneca Pharmaceuticals、 Baxter、 Otsuka America Pharmaceutical, Inc.、 Cumberland Pharmaceuticals, Inc.、 Relypsa, Inc.、 Sichuan Kelun Pharmaceutical Co., Ltd、 Xuzhou No. 5 Pharmaceutical Factory Co., Ltd、 Anhui Shuanghe Pharmaceutical Co., Ltd、 Shenyang Shuangding Pharmaceutical Co., Ltd、 Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd、 Hangzhou Minsheng Pharmaceutical Group Co., Ltdなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、電解質異常治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の電解質異常治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の電解質異常治療薬市場：タイプ別市場シェア、2022年
・経口液、注射剤

世界の電解質異常治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の電解質異常治療薬市場：用途別市場シェア、2022年
・病院、薬局、外来、その他

世界の電解質異常治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の電解質異常治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における電解質異常治療薬のグローバル売上、2018年-2023年
・主要企業における電解質異常治療薬のグローバル売上シェア、2022年
・主要企業における電解質異常治療薬のグローバル販売量、2018年-2023年
・主要企業における電解質異常治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Nomax Inc.、 Bristol Myers Squibb、 AbbVie、 Upsher-Smith Laboratories, Inc.、 AstraZeneca Pharmaceuticals、 Baxter、 Otsuka America Pharmaceutical, Inc.、 Cumberland Pharmaceuticals, Inc.、 Relypsa, Inc.、 Sichuan Kelun Pharmaceutical Co., Ltd、 Xuzhou No. 5 Pharmaceutical Factory Co., Ltd、 Anhui Shuanghe Pharmaceutical Co., Ltd、 Shenyang Shuangding Pharmaceutical Co., Ltd、 Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd、 Hangzhou Minsheng Pharmaceutical Group Co., Ltd

*************************************************************

・調査・分析レポートの概要
電解質異常治療薬市場の定義
市場セグメント
世界の電解質異常治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の電解質異常治療薬市場規模
世界の電解質異常治療薬市場規模：2022年 VS 2029年
世界の電解質異常治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの電解質異常治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の電解質異常治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口液、注射剤
電解質異常治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局、外来、その他
電解質異常治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別電解質異常治療薬市場規模 2022年と2029年
地域別電解質異常治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Nomax Inc.、 Bristol Myers Squibb、 AbbVie、 Upsher-Smith Laboratories, Inc.、 AstraZeneca Pharmaceuticals、 Baxter、 Otsuka America Pharmaceutical, Inc.、 Cumberland Pharmaceuticals, Inc.、 Relypsa, Inc.、 Sichuan Kelun Pharmaceutical Co., Ltd、 Xuzhou No. 5 Pharmaceutical Factory Co., Ltd、 Anhui Shuanghe Pharmaceutical Co., Ltd、 Shenyang Shuangding Pharmaceutical Co., Ltd、 Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd、 Hangzhou Minsheng Pharmaceutical Group Co., Ltd
...

Electrolyte disorder drugs are substances that supplement electrolytes needed by human beings. Common electrolytes refer to sodium, potassium, calcium and magnesium ions. If one of them is too low, the patient can be treated with symptomatic oral medicine. If the electrolyte of the patient is still disordered after taking the medicine, the patient should be treated with quiet medicine.
This report aims to provide a comprehensive presentation of the global market for Drugs for Electrolyte Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Electrolyte Disorders. This report contains market size and forecasts of Drugs for Electrolyte Disorders in global, including the following market information:
Global Drugs for Electrolyte Disorders Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Drugs for Electrolyte Disorders Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Drugs for Electrolyte Disorders companies in 2022 (%)
The global Drugs for Electrolyte Disorders market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oral Liquid Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drugs for Electrolyte Disorders include Nomax Inc., Bristol Myers Squibb, AbbVie, Upsher-Smith Laboratories, Inc., AstraZeneca Pharmaceuticals, Baxter, Otsuka America Pharmaceutical, Inc., Cumberland Pharmaceuticals, Inc. and Relypsa, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Electrolyte Disorders manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Electrolyte Disorders Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Drugs for Electrolyte Disorders Market Segment Percentages, by Type, 2022 (%)
Oral Liquid
Injection
Global Drugs for Electrolyte Disorders Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Drugs for Electrolyte Disorders Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Outpatient Department
Other
Global Drugs for Electrolyte Disorders Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Drugs for Electrolyte Disorders Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Electrolyte Disorders revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Drugs for Electrolyte Disorders revenues share in global market, 2022 (%)
Key companies Drugs for Electrolyte Disorders sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Drugs for Electrolyte Disorders sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nomax Inc.
Bristol Myers Squibb
AbbVie
Upsher-Smith Laboratories, Inc.
AstraZeneca Pharmaceuticals
Baxter
Otsuka America Pharmaceutical, Inc.
Cumberland Pharmaceuticals, Inc.
Relypsa, Inc.
Sichuan Kelun Pharmaceutical Co., Ltd
Xuzhou No. 5 Pharmaceutical Factory Co., Ltd
Anhui Shuanghe Pharmaceutical Co., Ltd
Shenyang Shuangding Pharmaceutical Co., Ltd
Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd
Hangzhou Minsheng Pharmaceutical Group Co., Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs for Electrolyte Disorders, market overview.
Chapter 2: Global Drugs for Electrolyte Disorders market size in revenue and volume.
Chapter 3: Detailed analysis of Drugs for Electrolyte Disorders manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs for Electrolyte Disorders in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Drugs for Electrolyte Disorders capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Drugs for Electrolyte Disorders Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Electrolyte Disorders Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Electrolyte Disorders Overall Market Size
2.1 Global Drugs for Electrolyte Disorders Market Size: 2022 VS 2029
2.2 Global Drugs for Electrolyte Disorders Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Drugs for Electrolyte Disorders Sales: 2018-2029
3 Company Landscape
3.1 Top Drugs for Electrolyte Disorders Players in Global Market
3.2 Top Global Drugs for Electrolyte Disorders Companies Ranked by Revenue
3.3 Global Drugs for Electrolyte Disorders Revenue by Companies
3.4 Global Drugs for Electrolyte Disorders Sales by Companies
3.5 Global Drugs for Electrolyte Disorders Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Drugs for Electrolyte Disorders Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Drugs for Electrolyte Disorders Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drugs for Electrolyte Disorders Players in Global Market
3.8.1 List of Global Tier 1 Drugs for Electrolyte Disorders Companies
3.8.2 List of Global Tier 2 and Tier 3 Drugs for Electrolyte Disorders Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Drugs for Electrolyte Disorders Market Size Markets, 2022 & 2029
4.1.2 Oral Liquid
4.1.3 Injection
4.2 By Type – Global Drugs for Electrolyte Disorders Revenue & Forecasts
4.2.1 By Type – Global Drugs for Electrolyte Disorders Revenue, 2018-2023
4.2.2 By Type – Global Drugs for Electrolyte Disorders Revenue, 2024-2029
4.2.3 By Type – Global Drugs for Electrolyte Disorders Revenue Market Share, 2018-2029
4.3 By Type – Global Drugs for Electrolyte Disorders Sales & Forecasts
4.3.1 By Type – Global Drugs for Electrolyte Disorders Sales, 2018-2023
4.3.2 By Type – Global Drugs for Electrolyte Disorders Sales, 2024-2029
4.3.3 By Type – Global Drugs for Electrolyte Disorders Sales Market Share, 2018-2029
4.4 By Type – Global Drugs for Electrolyte Disorders Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Drugs for Electrolyte Disorders Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Outpatient Department
5.1.5 Other
5.2 By Application – Global Drugs for Electrolyte Disorders Revenue & Forecasts
5.2.1 By Application – Global Drugs for Electrolyte Disorders Revenue, 2018-2023
5.2.2 By Application – Global Drugs for Electrolyte Disorders Revenue, 2024-2029
5.2.3 By Application – Global Drugs for Electrolyte Disorders Revenue Market Share, 2018-2029
5.3 By Application – Global Drugs for Electrolyte Disorders Sales & Forecasts
5.3.1 By Application – Global Drugs for Electrolyte Disorders Sales, 2018-2023
5.3.2 By Application – Global Drugs for Electrolyte Disorders Sales, 2024-2029
5.3.3 By Application – Global Drugs for Electrolyte Disorders Sales Market Share, 2018-2029
5.4 By Application – Global Drugs for Electrolyte Disorders Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Drugs for Electrolyte Disorders Market Size, 2022 & 2029
6.2 By Region – Global Drugs for Electrolyte Disorders Revenue & Forecasts
6.2.1 By Region – Global Drugs for Electrolyte Disorders Revenue, 2018-2023
6.2.2 By Region – Global Drugs for Electrolyte Disorders Revenue, 2024-2029
6.2.3 By Region – Global Drugs for Electrolyte Disorders Revenue Market Share, 2018-2029
6.3 By Region – Global Drugs for Electrolyte Disorders Sales & Forecasts
6.3.1 By Region – Global Drugs for Electrolyte Disorders Sales, 2018-2023
6.3.2 By Region – Global Drugs for Electrolyte Disorders Sales, 2024-2029
6.3.3 By Region – Global Drugs for Electrolyte Disorders Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Drugs for Electrolyte Disorders Revenue, 2018-2029
6.4.2 By Country – North America Drugs for Electrolyte Disorders Sales, 2018-2029
6.4.3 US Drugs for Electrolyte Disorders Market Size, 2018-2029
6.4.4 Canada Drugs for Electrolyte Disorders Market Size, 2018-2029
6.4.5 Mexico Drugs for Electrolyte Disorders Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Drugs for Electrolyte Disorders Revenue, 2018-2029
6.5.2 By Country – Europe Drugs for Electrolyte Disorders Sales, 2018-2029
6.5.3 Germany Drugs for Electrolyte Disorders Market Size, 2018-2029
6.5.4 France Drugs for Electrolyte Disorders Market Size, 2018-2029
6.5.5 U.K. Drugs for Electrolyte Disorders Market Size, 2018-2029
6.5.6 Italy Drugs for Electrolyte Disorders Market Size, 2018-2029
6.5.7 Russia Drugs for Electrolyte Disorders Market Size, 2018-2029
6.5.8 Nordic Countries Drugs for Electrolyte Disorders Market Size, 2018-2029
6.5.9 Benelux Drugs for Electrolyte Disorders Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Drugs for Electrolyte Disorders Revenue, 2018-2029
6.6.2 By Region – Asia Drugs for Electrolyte Disorders Sales, 2018-2029
6.6.3 China Drugs for Electrolyte Disorders Market Size, 2018-2029
6.6.4 Japan Drugs for Electrolyte Disorders Market Size, 2018-2029
6.6.5 South Korea Drugs for Electrolyte Disorders Market Size, 2018-2029
6.6.6 Southeast Asia Drugs for Electrolyte Disorders Market Size, 2018-2029
6.6.7 India Drugs for Electrolyte Disorders Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Drugs for Electrolyte Disorders Revenue, 2018-2029
6.7.2 By Country – South America Drugs for Electrolyte Disorders Sales, 2018-2029
6.7.3 Brazil Drugs for Electrolyte Disorders Market Size, 2018-2029
6.7.4 Argentina Drugs for Electrolyte Disorders Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Drugs for Electrolyte Disorders Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Drugs for Electrolyte Disorders Sales, 2018-2029
6.8.3 Turkey Drugs for Electrolyte Disorders Market Size, 2018-2029
6.8.4 Israel Drugs for Electrolyte Disorders Market Size, 2018-2029
6.8.5 Saudi Arabia Drugs for Electrolyte Disorders Market Size, 2018-2029
6.8.6 UAE Drugs for Electrolyte Disorders Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Nomax Inc.
7.1.1 Nomax Inc. Company Summary
7.1.2 Nomax Inc. Business Overview
7.1.3 Nomax Inc. Drugs for Electrolyte Disorders Major Product Offerings
7.1.4 Nomax Inc. Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.1.5 Nomax Inc. Key News & Latest Developments
7.2 Bristol Myers Squibb
7.2.1 Bristol Myers Squibb Company Summary
7.2.2 Bristol Myers Squibb Business Overview
7.2.3 Bristol Myers Squibb Drugs for Electrolyte Disorders Major Product Offerings
7.2.4 Bristol Myers Squibb Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.2.5 Bristol Myers Squibb Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Drugs for Electrolyte Disorders Major Product Offerings
7.3.4 AbbVie Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Upsher-Smith Laboratories, Inc.
7.4.1 Upsher-Smith Laboratories, Inc. Company Summary
7.4.2 Upsher-Smith Laboratories, Inc. Business Overview
7.4.3 Upsher-Smith Laboratories, Inc. Drugs for Electrolyte Disorders Major Product Offerings
7.4.4 Upsher-Smith Laboratories, Inc. Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.4.5 Upsher-Smith Laboratories, Inc. Key News & Latest Developments
7.5 AstraZeneca Pharmaceuticals
7.5.1 AstraZeneca Pharmaceuticals Company Summary
7.5.2 AstraZeneca Pharmaceuticals Business Overview
7.5.3 AstraZeneca Pharmaceuticals Drugs for Electrolyte Disorders Major Product Offerings
7.5.4 AstraZeneca Pharmaceuticals Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.5.5 AstraZeneca Pharmaceuticals Key News & Latest Developments
7.6 Baxter
7.6.1 Baxter Company Summary
7.6.2 Baxter Business Overview
7.6.3 Baxter Drugs for Electrolyte Disorders Major Product Offerings
7.6.4 Baxter Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.6.5 Baxter Key News & Latest Developments
7.7 Otsuka America Pharmaceutical, Inc.
7.7.1 Otsuka America Pharmaceutical, Inc. Company Summary
7.7.2 Otsuka America Pharmaceutical, Inc. Business Overview
7.7.3 Otsuka America Pharmaceutical, Inc. Drugs for Electrolyte Disorders Major Product Offerings
7.7.4 Otsuka America Pharmaceutical, Inc. Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.7.5 Otsuka America Pharmaceutical, Inc. Key News & Latest Developments
7.8 Cumberland Pharmaceuticals, Inc.
7.8.1 Cumberland Pharmaceuticals, Inc. Company Summary
7.8.2 Cumberland Pharmaceuticals, Inc. Business Overview
7.8.3 Cumberland Pharmaceuticals, Inc. Drugs for Electrolyte Disorders Major Product Offerings
7.8.4 Cumberland Pharmaceuticals, Inc. Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.8.5 Cumberland Pharmaceuticals, Inc. Key News & Latest Developments
7.9 Relypsa, Inc.
7.9.1 Relypsa, Inc. Company Summary
7.9.2 Relypsa, Inc. Business Overview
7.9.3 Relypsa, Inc. Drugs for Electrolyte Disorders Major Product Offerings
7.9.4 Relypsa, Inc. Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.9.5 Relypsa, Inc. Key News & Latest Developments
7.10 Sichuan Kelun Pharmaceutical Co., Ltd
7.10.1 Sichuan Kelun Pharmaceutical Co., Ltd Company Summary
7.10.2 Sichuan Kelun Pharmaceutical Co., Ltd Business Overview
7.10.3 Sichuan Kelun Pharmaceutical Co., Ltd Drugs for Electrolyte Disorders Major Product Offerings
7.10.4 Sichuan Kelun Pharmaceutical Co., Ltd Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.10.5 Sichuan Kelun Pharmaceutical Co., Ltd Key News & Latest Developments
7.11 Xuzhou No. 5 Pharmaceutical Factory Co., Ltd
7.11.1 Xuzhou No. 5 Pharmaceutical Factory Co., Ltd Company Summary
7.11.2 Xuzhou No. 5 Pharmaceutical Factory Co., Ltd Drugs for Electrolyte Disorders Business Overview
7.11.3 Xuzhou No. 5 Pharmaceutical Factory Co., Ltd Drugs for Electrolyte Disorders Major Product Offerings
7.11.4 Xuzhou No. 5 Pharmaceutical Factory Co., Ltd Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.11.5 Xuzhou No. 5 Pharmaceutical Factory Co., Ltd Key News & Latest Developments
7.12 Anhui Shuanghe Pharmaceutical Co., Ltd
7.12.1 Anhui Shuanghe Pharmaceutical Co., Ltd Company Summary
7.12.2 Anhui Shuanghe Pharmaceutical Co., Ltd Drugs for Electrolyte Disorders Business Overview
7.12.3 Anhui Shuanghe Pharmaceutical Co., Ltd Drugs for Electrolyte Disorders Major Product Offerings
7.12.4 Anhui Shuanghe Pharmaceutical Co., Ltd Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.12.5 Anhui Shuanghe Pharmaceutical Co., Ltd Key News & Latest Developments
7.13 Shenyang Shuangding Pharmaceutical Co., Ltd
7.13.1 Shenyang Shuangding Pharmaceutical Co., Ltd Company Summary
7.13.2 Shenyang Shuangding Pharmaceutical Co., Ltd Drugs for Electrolyte Disorders Business Overview
7.13.3 Shenyang Shuangding Pharmaceutical Co., Ltd Drugs for Electrolyte Disorders Major Product Offerings
7.13.4 Shenyang Shuangding Pharmaceutical Co., Ltd Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.13.5 Shenyang Shuangding Pharmaceutical Co., Ltd Key News & Latest Developments
7.14 Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd
7.14.1 Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd Company Summary
7.14.2 Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd Business Overview
7.14.3 Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd Drugs for Electrolyte Disorders Major Product Offerings
7.14.4 Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.14.5 Shanghai Xinyi Jinzhu Pharmaceutical Co., Ltd Key News & Latest Developments
7.15 Hangzhou Minsheng Pharmaceutical Group Co., Ltd
7.15.1 Hangzhou Minsheng Pharmaceutical Group Co., Ltd Company Summary
7.15.2 Hangzhou Minsheng Pharmaceutical Group Co., Ltd Business Overview
7.15.3 Hangzhou Minsheng Pharmaceutical Group Co., Ltd Drugs for Electrolyte Disorders Major Product Offerings
7.15.4 Hangzhou Minsheng Pharmaceutical Group Co., Ltd Drugs for Electrolyte Disorders Sales and Revenue in Global (2018-2023)
7.15.5 Hangzhou Minsheng Pharmaceutical Group Co., Ltd Key News & Latest Developments
8 Global Drugs for Electrolyte Disorders Production Capacity, Analysis
8.1 Global Drugs for Electrolyte Disorders Production Capacity, 2018-2029
8.2 Drugs for Electrolyte Disorders Production Capacity of Key Manufacturers in Global Market
8.3 Global Drugs for Electrolyte Disorders Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Drugs for Electrolyte Disorders Supply Chain Analysis
10.1 Drugs for Electrolyte Disorders Industry Value Chain
10.2 Drugs for Electrolyte Disorders Upstream Market
10.3 Drugs for Electrolyte Disorders Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Drugs for Electrolyte Disorders Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ファモチジン医薬品のグローバル市場展望 2023年-2029年：錠剤、注射剤、その他
  • 医薬品用発酵エンジニアリングのグローバル市場展望 2023年-2029年：モノクローナル抗体、抗生物質、インスリン、ヒト成長ホルモン、医薬品アミノ酸、その他
  • 世界の不安障害・パニック障害治療薬市場2022年：市場規模予測（～2028年）
  • ポルフィリン症治療薬のグローバル市場展望 2023年-2029年：経口式、注射式
  • セマグルチド薬のグローバル市場展望 2023年-2029年：注射式、経口式
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8488 )"電解質異常治療薬のグローバル市場展望 2023年-2029年：経口液、注射剤" (英文：Drugs for Electrolyte Disorders Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。